Back to Search Start Over

The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins

Authors :
Noordzij, J.G. (Jeroen)
Bruin-Versteeg, S. (Sandra) de
Verkaik, N.S. (Nicole)
Vossen, J.M.J.J. (Jaak)
Groot, R. (Ronald) de
Bernatowska, E. (Ewa)
Langerak, A.W. (Anton)
Gent, D.C. (Dik) van
Dongen, J.J.M. (Jacques) van
Noordzij, J.G. (Jeroen)
Bruin-Versteeg, S. (Sandra) de
Verkaik, N.S. (Nicole)
Vossen, J.M.J.J. (Jaak)
Groot, R. (Ronald) de
Bernatowska, E. (Ewa)
Langerak, A.W. (Anton)
Gent, D.C. (Dik) van
Dongen, J.J.M. (Jacques) van
Publication Year :
2002

Abstract

The protein products of the recombination activating genes (RAG1 and RAG2) initiate the formation of immunoglobulin (Ig) and T-cell receptors, which are essential for B- and T-cell development, respectively. Mutations in the RAG genes result in severe combined immunodeficiency disease (SCID), generally characterized by the absence of mature B and T lymphocytes, but presence of natural killer (NK) cells. Biochemically, mutations in the RAG genes result either in nonfunctional proteins or in proteins

Details

Database :
OAIster
Notes :
application/pdf, Blood, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn929962135
Document Type :
Electronic Resource